BDSX Biodesix: Company Short-Term Debts

Symbol and logo of brand Biodesix Corp (BDSX)

Biodesix, Inc. (BDSX) partnerships with oncology centers and pharma behemoths to implement targeted therapy are creating powerful market momentum. Total short-term debt illustrates the company's financial stability, while the 0.00 metric reflects current dynamics. Growth in the US B2B segment is scaling lung cancer diagnostics, and the recruitment of AI specialists and data scientists is strengthening the technological potential of the R&D center.

BDSX Biodesix Inc Company Short-Term Loans and Borrowings (07/04/2022 - 10/30/2026)

Summary analytical data breakdowns for Biodesix Corporation (BDSX)

- stock price and consensus target price:
Stock Price Biodesix|BDSX - Consensus Target
- company stock capitalization data:
Market Capitalization Biodesix, Inc.|BDSX - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Biodesix|BDSX - Accounting Value of Company|Market Cap to Net Assets Ratio biodesix.com|BDSX - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Biodesix, Inc.|BDSX - Long-Term Debt to Capital|Short-Term Debt to Equity Biodesix, Inc.|BDSX - Company Aggregate Debt|Debts to Book Capitalization Biodesix, Inc.|BDSX - Company Long-Term Debts|Company Short-Term Debt Biodesix|Quick Liquidity Indicator biodesix.com
- earnings and multiples data:
BDSX - Company Net Income
Fundamental valuation:Biodesix (BDSX)
Manufactured products of Biodesix, Inc.

Due to the high cost of its lung cancer diagnostic rapid tests, Biodesix, Inc. (BDSX) possesses significant pricing power in its dealings with counterparties. By analyzing the volatility of short-term debt, an investor assesses the volume of obligations maturing within one year, where a decrease in the amount minimizes default risk but may indicate underinvestment in the technological development of production.

Competitors of Biodesix, Inc. (BDSX)

Caris Life Sciences - Company Short-Term Debts|Guardant Health Inc (GH) - Company Current Liabilities|VCYT: Company Short-Term Debts|Short-Term Debt Celcuity Therapeutics (CELC)|Company Short-Term Debt GRAIL, Inc.|MYGN: Company Short-Term Loans and Borrowings|Company Current Liabilities CSTL (Castle Biosciences, Inc.)|BNR (Burning Rock Biotech Limited) - Company Short-Term Loans and Borrowings|Company Short-Term Debts VNRX (VolitionRx)|Company Short-Term Debts Precipio Inc PRPO|CHEK - Company Short-Term Debt|MYNZ (mainzbiomed.com) - Company Short-Term Indebtedness|OCX: Company Short-Term Debts